Payer

The company has $6 million in seed funding from Lightspeed Venture Partners, Define Ventures and Qiming Venture Partners USA.   

Researchers found patients who used reSET-O along with buprenorphine and counseling lowered their healthcare costs by $2,385 per person in the six months after they started using the app, compared with the six months before.

Representatives from Accenture, The Chartis Group, ZS and HIMSS talk about what's to come at HIMSS21 and beyond.

During the COVID-19 pandemic rates of depression, anxiety and substance abuse increased. 

Crossover Health CEO Scott Shreeve explains how healthcare is reorganizing itself around technology.

HIMSS editors talk about what they heard at the State of Healthcare online event, and HIMSS CEO Hal Wolf drops by for a preview of the sequel, the Future of Healthcare event at HIMSS21.

At HIMSS' State of Healthcare event on June 15, Oscar CEO Mario Schlosser will discuss how the insurance space has adjusted to the COVID-19 demands. 

Patient and providers are looking to remote monitoring for the future, but incentive structures fall short. 

The San Clemente, California-based company is aiming to expand its payer- and employer-focused care platform with the funds.

Published yesterday in PLoS ONE, the data suggests an alternative to the six-minute walk test often conducted in clinics to measure functional capacity.